COLLAGENASE SANTYL

COLLAGENASE SANTYL was reported 1690 times

COLLAGENASE SANTYL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIATION ALOPECIA 2 0.2000
1 APPLICATION SITE PALLOR 4 0.1212
2 CONGENITAL NEUROPATHY 2 0.0800
3 TISSUE DISCOLOURATION 4 0.0702
4 HIP DISARTICULATION 1 0.0625
5 WOUND COMPLICATION 159 0.0463
6 APPLICATION SITE CELLULITIS 3 0.0448
7 ADMINISTRATION SITE CELLULITIS 1 0.0286
8 ILIAC ARTERY EMBOLISM 1 0.0270
9 DERMAL ABSORPTION INCREASED 1 0.0244
10 WOUND INFECTION PSEUDOMONAS 7 0.0224
11 ISCHAEMIC SKIN ULCER 2 0.0215
12 PERIPHERAL ARTERY STENT INSERTION 1 0.0204
13 APPLICATION SITE NECROSIS 2 0.0194
14 WOUND DECOMPOSITION 3 0.0181
15 ISCHAEMIC LIMB PAIN 1 0.0161
16 BURKHOLDERIA TEST POSITIVE 2 0.0161
17 ACTINIC ELASTOSIS 1 0.0132
18 APPLICATION SITE COLDNESS 1 0.0118
19 WOUND SECRETION 44 0.0112
20 ARTHROFIBROSIS 1 0.0098
21 INCISION SITE CELLULITIS 1 0.0093
22 POST POLIO SYNDROME 1 0.0089
23 WOUND DRAINAGE 7 0.0088
24 NAIL BED TENDERNESS 1 0.0088
25 MALABSORPTION FROM ADMINISTRATION SITE 2 0.0086
26 ARTERIAL RESTENOSIS 1 0.0085
27 WOUND NECROSIS 4 0.0083
28 APPLICATION SITE PUSTULES 3 0.0082
29 PHANTOM PAIN 2 0.0081
30 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
31 APPLICATION SITE INFECTION 4 0.0079
32 INFESTATION 2 0.0077
33 APPLICATION SITE DISCHARGE 8 0.0069
34 APPLICATION SITE ODOUR 1 0.0069
35 PERINEAL INJURY 1 0.0066
36 ABDOMINAL WALL WOUND 1 0.0065
37 GALLBLADDER NECROSIS 1 0.0063
38 CELLULITIS STREPTOCOCCAL 1 0.0063
39 INTESTINAL ANGIOEDEMA 3 0.0063
40 LUMBOSACRAL RADICULOPATHY 1 0.0062
41 PERIPHERAL NERVE LESION 2 0.0061
42 MITRAL VALVE SCLEROSIS 1 0.0058
43 GENITOURINARY SYMPTOM 1 0.0055
44 ESCHAR 4 0.0055
45 ACUTE HEPATITIS C 1 0.0055
46 ESSENTIAL THROMBOCYTHAEMIA 2 0.0054
47 ADMINISTRATION SITE DISCOMFORT 1 0.0053
48 B PRECURSOR TYPE ACUTE LEUKAEMIA 2 0.0052
49 CHRONIC PIGMENTED PURPURA 1 0.0051
50 EXSANGUINATION 1 0.0050
51 APPLICATION SITE PAIN 109 0.0049
52 WOUND INFECTION BACTERIAL 2 0.0048
53 LEPROSY 1 0.0048
54 DRY GANGRENE 3 0.0047
55 WOUND INFECTION STAPHYLOCOCCAL 8 0.0046
56 TISSUE INJURY 2 0.0046
57 DRUG DELIVERY DEVICE IMPLANTATION 1 0.0045
58 NECROTISING SOFT TISSUE INFECTION 1 0.0043
59 NAIL BED INFECTION 1 0.0042
60 WOUND INFECTION 46 0.0042
61 APPLICATION SITE DISCOLOURATION 17 0.0042
62 MENSTRUAL CLOTS 1 0.0042
63 DIABETIC VASCULAR DISORDER 1 0.0040
64 APPLICATION SITE HAEMORRHAGE 11 0.0040
65 AMPUTATION 5 0.0040
66 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
67 PERIORBITAL CELLULITIS 2 0.0037
68 HORMONE RECEPTOR POSITIVE BREAST CANCER 1 0.0037
69 ARTERIAL STENT INSERTION 1 0.0037
70 ANGIOGRAM 1 0.0036
71 SKIN WOUND 6 0.0035
72 WOUND HAEMORRHAGE 13 0.0035
73 FOOT AMPUTATION 5 0.0034
74 PREMATURE AGEING 1 0.0034
75 TOE AMPUTATION 17 0.0033
76 FEAR OF EATING 1 0.0032
77 HYPERPARATHYROIDISM SECONDARY 8 0.0032
78 OESOPHAGEAL FISTULA 1 0.0031
79 APPLICATION SITE EROSION 4 0.0031
80 APPLICATION SITE OEDEMA 1 0.0031
81 ADMINISTRATION SITE SWELLING 1 0.0031
82 PENILE OEDEMA 1 0.0031
83 CENTRAL HYPOTHYROIDISM 1 0.0030
84 COAGULATION TIME SHORTENED 1 0.0030
85 INFLAMMATION OF WOUND 1 0.0030
86 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
87 METASTASES TO CHEST WALL 1 0.0029
88 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
89 MENISCUS OPERATION 1 0.0028
90 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 1 0.0027
91 ALBUMIN URINE PRESENT 1 0.0026
92 PERIPHERAL VASCULAR DISORDER 13 0.0025
93 EXCESSIVE GRANULATION TISSUE 2 0.0025
94 PERIPHERAL CIRCULATORY FAILURE 1 0.0024
95 LEG AMPUTATION 10 0.0024
96 METASTASES TO SPLEEN 1 0.0024
97 NEPHROGENIC ANAEMIA 11 0.0024
98 GENITAL LESION 1 0.0024
99 NAIL BED DISORDER 1 0.0023
100 DECUBITUS ULCER 19 0.0023
101 ANAEMIA OF CHRONIC DISEASE 2 0.0022
102 LAPAROTOMY 1 0.0022
103 APPLICATION SITE INFLAMMATION 3 0.0022
104 SKIN GRAFT 2 0.0022
105 EHLERS-DANLOS SYNDROME 1 0.0022
106 PERIPHERAL ARTERY OCCLUSION 3 0.0021
107 MECHANICAL URTICARIA 1 0.0021
108 INFECTED SKIN ULCER 4 0.0021
109 WOUND 59 0.0021
110 PERIPHERAL ARTERY STENOSIS 1 0.0021
111 DRAINAGE 1 0.0020
112 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
113 LENTIGO 1 0.0020
114 MICROCYTIC ANAEMIA 4 0.0019
115 INADEQUATE DIET 1 0.0019
116 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
117 IMPAIRED HEALING 61 0.0019
118 INFUSION SITE MASS 2 0.0018
119 STREPTOCOCCAL BACTERAEMIA 2 0.0018
120 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
121 ENCEPHALOMALACIA 1 0.0018
122 ADMINISTRATION SITE PAIN 2 0.0017
123 DIAPHRAGMATIC PARALYSIS 1 0.0017
124 ESSENTIAL HYPERTENSION 3 0.0016
125 NAIL PSORIASIS 1 0.0016
126 OSTEOMYELITIS CHRONIC 1 0.0016
127 CORTISOL INCREASED 1 0.0016
128 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
129 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
130 MUCOSAL DISCOLOURATION 1 0.0016
131 NEUROPATHIC ARTHROPATHY 1 0.0015
132 ENTEROCOCCUS TEST POSITIVE 1 0.0015
133 CELLULITIS STAPHYLOCOCCAL 1 0.0015
134 EMBOLIC CEREBRAL INFARCTION 1 0.0015
135 WOUND DEHISCENCE 5 0.0015
136 PROCEDURAL ANXIETY 1 0.0015
137 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
138 APPLICATION SITE ULCER 1 0.0014
139 DIABETIC ULCER 1 0.0014
140 CRYOGLOBULINAEMIA 1 0.0014
141 APPLICATION SITE VESICLES 9 0.0014
142 BLISTER RUPTURE 1 0.0013
143 GANGRENE 8 0.0013
144 OESOPHAGEAL DISCOMFORT 1 0.0013
145 ARTERIAL RUPTURE 1 0.0013
146 INHIBITORY DRUG INTERACTION 2 0.0013
147 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
148 ANAL ULCER 1 0.0012
149 OSTEOMYELITIS 22 0.0012
150 OCULAR VASCULAR DISORDER 1 0.0012
151 INCISION SITE COMPLICATION 1 0.0012
152 CULTURE POSITIVE 1 0.0012
153 MYCOTIC ALLERGY 1 0.0012
154 FOOD REFUSAL 1 0.0011
155 SKIN ULCER 29 0.0011
156 NASAL OEDEMA 2 0.0011
157 END STAGE RENAL DISEASE 20 0.0011
158 METASTASES TO ADRENALS 1 0.0011
159 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
160 BRAIN STEM HAEMORRHAGE 1 0.0011
161 COR PULMONALE 1 0.0010
162 APPLICATION SITE BRUISE 1 0.0010
163 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
164 MUCOSAL DRYNESS 2 0.0010
165 APPLICATION SITE ERYTHEMA 26 0.0010
166 REBOUND ACID HYPERSECRETION 3 0.0010
167 DIABETIC FOOT 3 0.0010
168 PERIPHERAL VENOUS DISEASE 4 0.0010
169 APPLICATION SITE EXFOLIATION 4 0.0010
170 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
171 BURNS THIRD DEGREE 1 0.0009
172 VASCULAR OCCLUSION 2 0.0009
173 ALLERGY TO ANIMAL 1 0.0009
174 NEUROMYOPATHY 1 0.0009
175 RENAL TUBULAR NECROSIS 9 0.0009
176 HOSPICE CARE 9 0.0009
177 PERIRECTAL ABSCESS 1 0.0009
178 ARTERIAL HAEMORRHAGE 1 0.0009
179 DISEASE COMPLICATION 4 0.0009
180 APPLICATION SITE REACTION 6 0.0009
181 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
182 PRODUCT PACKAGING CONFUSION 2 0.0008
183 PHARYNGEAL HAEMORRHAGE 1 0.0008
184 APPLICATION SITE BURN 4 0.0008
185 HYPERNATRAEMIA 4 0.0008
186 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
187 FRACTURED COCCYX 1 0.0008
188 BRONCHIAL SECRETION RETENTION 1 0.0008
189 LIP HAEMORRHAGE 1 0.0008
190 APPLICATION SITE PARAESTHESIA 1 0.0008
191 ANAEMIA POSTOPERATIVE 1 0.0008
192 ANAL FISTULA 4 0.0007
193 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
194 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
195 RHINALGIA 2 0.0007
196 APPLICATION SITE IRRITATION 9 0.0007
197 DISCHARGE 1 0.0007
198 ANGIOPATHY 4 0.0007
199 PROTHROMBIN TIME SHORTENED 1 0.0007
200 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
201 NECK MASS 2 0.0007
202 POOR PERIPHERAL CIRCULATION 3 0.0007
203 PURULENT DISCHARGE 3 0.0007
204 SCAB 8 0.0007
205 PELVIC VENOUS THROMBOSIS 1 0.0007
206 GASTROINTESTINAL NECROSIS 2 0.0007
207 PULMONARY PAIN 2 0.0007
208 CHRONIC KIDNEY DISEASE 52 0.0007
209 ONYCHOMYCOSIS 3 0.0007
210 IMPETIGO 1 0.0007
211 ANGIOPLASTY 1 0.0007
212 METABOLIC ENCEPHALOPATHY 2 0.0007
213 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
214 NEURITIS 1 0.0006
215 SKIN TIGHTNESS 3 0.0006
216 RESPIRATORY RATE DECREASED 2 0.0006
217 FUNGAEMIA 1 0.0006
218 ULCER 10 0.0006
219 RENAL CELL CARCINOMA 3 0.0006
220 BREAST ENLARGEMENT 2 0.0006
221 INTESTINAL POLYP 1 0.0006
222 ESCHERICHIA INFECTION 5 0.0006
223 SKIN INJURY 2 0.0006
224 APPLICATION SITE SWELLING 3 0.0006
225 ARTHROPOD STING 1 0.0006
226 MEDICAL PROCEDURE 1 0.0006
227 ENTEROBACTER INFECTION 1 0.0006
228 POST PROCEDURAL HAEMATOMA 1 0.0006
229 EROSIVE OESOPHAGITIS 1 0.0006
230 APPLICATION SITE DRYNESS 2 0.0006
231 ENDOCARDITIS 3 0.0006
232 CHOREA 1 0.0006
233 BURNS SECOND DEGREE 1 0.0006
234 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
235 APPLICATION SITE DISCOMFORT 1 0.0006
236 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
237 CATHETER PLACEMENT 1 0.0005
238 NECROSIS 3 0.0005
239 CELLULITIS 27 0.0005
240 BLADDER SPASM 1 0.0005
241 MECHANICAL VENTILATION 1 0.0005
242 PANCREATIC CYST 1 0.0005
243 SKIN ATROPHY 3 0.0005
244 THYROID MASS 2 0.0005
245 ATROPHY 1 0.0005
246 ABDOMINAL WALL HAEMATOMA 1 0.0005
247 COLOSTOMY 1 0.0005
248 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
249 LOCALISED INFECTION 12 0.0005
250 PRE-EXISTING CONDITION IMPROVED 3 0.0005
251 LIVEDO RETICULARIS 1 0.0005
252 SCREAMING 3 0.0005
253 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
254 ACUTE RESPIRATORY FAILURE 9 0.0005
255 CATHETER SITE ERYTHEMA 1 0.0005
256 BLOOD TESTOSTERONE INCREASED 1 0.0005
257 HYPERPHOSPHATAEMIA 1 0.0005
258 APPLICATION SITE SCAB 1 0.0005
259 TENDON DISORDER 3 0.0005
260 CLOSTRIDIUM TEST POSITIVE 1 0.0005
261 CATHETERISATION CARDIAC 2 0.0005
262 DEATH 388 0.0004
263 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
264 MALNUTRITION 5 0.0004
265 FEAR OF DEATH 1 0.0004
266 POSTOPERATIVE WOUND INFECTION 3 0.0004
267 REACTION TO EXCIPIENT 1 0.0004
268 ARTHRITIS INFECTIVE 2 0.0004
269 MENOPAUSAL SYMPTOMS 1 0.0004
270 PERFORMANCE STATUS DECREASED 2 0.0004
271 NEPHROPATHY 4 0.0004
272 ESCHERICHIA BACTERAEMIA 1 0.0004
273 THERMAL BURN 3 0.0004
274 BACTERAEMIA 5 0.0004
275 ENTEROCOCCAL INFECTION 2 0.0004
276 STAPHYLOCOCCAL SEPSIS 2 0.0004
277 FOOT OPERATION 2 0.0004
278 DIABETIC NEUROPATHY 2 0.0004
279 HEART INJURY 1 0.0004
280 GASTROINTESTINAL TUBE INSERTION 1 0.0004
281 FLUID INTAKE REDUCED 2 0.0004
282 CATHETER SITE HAEMORRHAGE 1 0.0004
283 PRODUCT ADMINISTRATION ERROR 8 0.0004
284 PARKINSON'S DISEASE 1 0.0004
285 CANCER PAIN 1 0.0004
286 PRODUCT COLOUR ISSUE 2 0.0004
287 SKIN NECROSIS 2 0.0004
288 CATHETER SITE PAIN 1 0.0004
289 BURNING SENSATION 27 0.0004
290 RADICULOPATHY 1 0.0004
291 SCRATCH 4 0.0004
292 FURUNCLE 3 0.0004
293 ABDOMINAL MASS 1 0.0004
294 RENAL INJURY 11 0.0004
295 CHONDROPATHY 1 0.0004
296 LIMB INJURY 10 0.0004
297 ORAL FUNGAL INFECTION 1 0.0004
298 NONSPECIFIC REACTION 2 0.0004
299 PLEURITIC PAIN 1 0.0004
300 EXPIRED PRODUCT ADMINISTERED 12 0.0004
301 RASH MORBILLIFORM 1 0.0004
302 ENDOTRACHEAL INTUBATION 1 0.0004
303 PRODUCT LEAKAGE 2 0.0004
304 BLISTER 20 0.0004
305 NEUTROPHIL COUNT ABNORMAL 1 0.0004
306 PSEUDOMONAS INFECTION 3 0.0003
307 PARAPLEGIA 1 0.0003
308 ESCHERICHIA SEPSIS 1 0.0003
309 RALES 2 0.0003
310 ACUTE KIDNEY INJURY 52 0.0003
311 CREPITATIONS 1 0.0003
312 CENTRAL VENOUS CATHETERISATION 1 0.0003
313 RENAL FAILURE 44 0.0003
314 MASTICATION DISORDER 1 0.0003
315 DYSAESTHESIA 1 0.0003
316 INCREASED TENDENCY TO BRUISE 3 0.0003
317 INTRACARDIAC THROMBUS 1 0.0003
318 RECTAL CANCER 1 0.0003
319 DIASTOLIC DYSFUNCTION 1 0.0003
320 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
321 BLOOD CREATININE DECREASED 1 0.0003
322 INVESTIGATION 1 0.0003
323 ARTERIOSCLEROSIS 3 0.0003
324 LEUKAEMIA 3 0.0003
325 UNRESPONSIVE TO STIMULI 8 0.0003
326 PORTAL VEIN THROMBOSIS 1 0.0003
327 LIVER ABSCESS 1 0.0003
328 BACTERIAL SEPSIS 1 0.0003
329 PLATELET COUNT INCREASED 4 0.0003
330 SKIN DISCOLOURATION 14 0.0003
331 STAPHYLOCOCCAL INFECTION 10 0.0003
332 PEPTIC ULCER 1 0.0003
333 LYME DISEASE 1 0.0003
334 NEPHRITIS 1 0.0003
335 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
336 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
337 SKIN EXFOLIATION 25 0.0003
338 DROOLING 2 0.0003
339 HYPOPNOEA 1 0.0003
340 NECROTISING FASCIITIS 1 0.0003
341 DIALYSIS 4 0.0003
342 GLOSSITIS 1 0.0003
343 FIBRIN D DIMER INCREASED 1 0.0003
344 DECREASED ACTIVITY 3 0.0003
345 PYODERMA GANGRENOSUM 1 0.0003
346 SEPSIS 31 0.0003
347 BONE LESION 1 0.0003
348 BLOOD PHOSPHORUS DECREASED 1 0.0003
349 FOOD INTOLERANCE 1 0.0003
350 SKIN DISORDER 9 0.0003
351 NERVE INJURY 3 0.0003
352 NEURODERMATITIS 1 0.0003
353 BONE DENSITY ABNORMAL 1 0.0003
354 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
355 APPLICATION SITE PRURITUS 6 0.0003
356 PARANASAL SINUS DISCOMFORT 1 0.0003
357 BLOOD COUNT ABNORMAL 4 0.0003
358 DERMATITIS CONTACT 3 0.0003
359 TROPONIN INCREASED 2 0.0003
360 RENAL DISORDER 12 0.0003
361 SPLENOMEGALY 3 0.0003
362 ORAL INFECTION 1 0.0003
363 PROCEDURAL HAEMORRHAGE 1 0.0003
364 COVID-19 PNEUMONIA 3 0.0003
365 POLYDIPSIA 1 0.0003
366 GINGIVAL PAIN 2 0.0003
367 OESOPHAGEAL CANDIDIASIS 1 0.0003
368 CEREBRAL ATROPHY 1 0.0003
369 ORGAN FAILURE 1 0.0002
370 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
371 BLOOD POTASSIUM INCREASED 4 0.0002
372 PERIPHERAL ISCHAEMIA 1 0.0002
373 MUSCLE SPASTICITY 3 0.0002
374 HOSPITALISATION 37 0.0002
375 PNEUMONIA ASPIRATION 6 0.0002
376 CONGESTIVE CARDIOMYOPATHY 1 0.0002
377 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
378 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
379 AORTIC VALVE INCOMPETENCE 1 0.0002
380 EATING DISORDER 5 0.0002
381 CARDIAC FAILURE CHRONIC 1 0.0002
382 RETCHING 5 0.0002
383 PRODUCT DISPENSING ISSUE 1 0.0002
384 BLOOD MAGNESIUM DECREASED 2 0.0002
385 SEPTIC SHOCK 10 0.0002
386 URINE OUTPUT DECREASED 2 0.0002
387 BLOOD CALCIUM INCREASED 2 0.0002
388 DYSPHEMIA 1 0.0002
389 HAEMORRHAGIC ANAEMIA 1 0.0002
390 ABDOMINAL ABSCESS 1 0.0002
391 HAEMOLYTIC ANAEMIA 2 0.0002
392 DRUG EFFECT DELAYED 1 0.0002
393 DRUG EFFECT INCOMPLETE 8 0.0002
394 RESTLESS LEGS SYNDROME 4 0.0002
395 PRODUCT AVAILABILITY ISSUE 5 0.0002
396 ABDOMINAL HERNIA 1 0.0002
397 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
398 ISCHAEMIA 1 0.0002
399 UROSEPSIS 2 0.0002
400 MENTAL STATUS CHANGES 6 0.0002
401 HEPATIC ENCEPHALOPATHY 2 0.0002
402 FLANK PAIN 2 0.0002
403 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
404 BLOOD URINE PRESENT 4 0.0002
405 MUSCULOSKELETAL DISORDER 4 0.0002
406 EYE INFLAMMATION 2 0.0002
407 MEDICATION RESIDUE PRESENT 1 0.0002
408 HYPOVOLAEMIC SHOCK 1 0.0002
409 INFECTION 30 0.0002
410 HYPERCHOLESTEROLAEMIA 2 0.0002
411 RASH VESICULAR 1 0.0002
412 EAR PAIN 4 0.0002
413 SKIN HAEMORRHAGE 3 0.0002
414 HYPERVOLAEMIA 1 0.0002
415 INFLAMMATORY MARKER INCREASED 1 0.0002
416 PERIPHERAL SWELLING 31 0.0002
417 PROTEIN URINE PRESENT 1 0.0002
418 BRAIN INJURY 2 0.0002
419 PATHOLOGICAL FRACTURE 1 0.0002
420 HYPOPHAGIA 5 0.0002
421 FEMORAL NECK FRACTURE 1 0.0002
422 THYROID DISORDER 3 0.0002
423 CEREBRAL ISCHAEMIA 1 0.0002
424 FAILURE TO THRIVE 1 0.0002
425 TENDERNESS 2 0.0002
426 WEIGHT FLUCTUATION 2 0.0002
427 ANORECTAL DISCOMFORT 1 0.0002
428 ABSCESS 3 0.0002
429 SURGERY 11 0.0002
430 CARDIAC FAILURE CONGESTIVE 15 0.0002
431 HIP FRACTURE 6 0.0002
432 PRODUCT RESIDUE PRESENT 1 0.0002
433 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
434 ASPIRATION 2 0.0002
435 JAW DISORDER 1 0.0002
436 FAECALOMA 1 0.0002
437 HYPERKERATOSIS 1 0.0002
438 GASTRIC ULCER HAEMORRHAGE 1 0.0002
439 HEART RATE ABNORMAL 1 0.0002
440 SKIN INFECTION 2 0.0002
441 BLOOD CALCIUM DECREASED 2 0.0002
442 PERONEAL NERVE PALSY 1 0.0002
443 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
444 SCAR 3 0.0002
445 MICTURITION URGENCY 2 0.0002
446 METASTASES TO LUNG 2 0.0002
447 PRODUCT LABEL CONFUSION 1 0.0002
448 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
449 DECREASED INTEREST 1 0.0002
450 HYPERLIPIDAEMIA 2 0.0002
451 TOOTHACHE 3 0.0002
452 INJECTION SITE VESICLES 1 0.0002
453 URINARY TRACT INFECTION 28 0.0002
454 DRUG ADMINISTRATION ERROR 5 0.0002
455 ENCEPHALOPATHY 4 0.0002
456 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
457 CARDIOMEGALY 2 0.0002
458 SMALL INTESTINAL OBSTRUCTION 2 0.0002
459 SPINAL OPERATION 2 0.0002
460 TENDON RUPTURE 2 0.0002
461 HYPERCALCAEMIA 2 0.0002
462 PIGMENTATION DISORDER 1 0.0002
463 CONJUNCTIVITIS 3 0.0002
464 CYST 2 0.0002
465 THINKING ABNORMAL 3 0.0002
466 ILEUS 2 0.0002
467 BACTERIAL INFECTION 3 0.0002
468 MIDDLE INSOMNIA 3 0.0002
469 INFUSION SITE EXTRAVASATION 1 0.0002
470 BLEPHAROSPASM 1 0.0002
471 THERAPY CESSATION 8 0.0002
472 ROTATOR CUFF SYNDROME 2 0.0002
473 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
474 PROCTALGIA 1 0.0002
475 HAEMOGLOBIN ABNORMAL 1 0.0002
476 HERNIA 3 0.0002
477 EXPOSURE VIA SKIN CONTACT 4 0.0002
478 RESPIRATORY TRACT INFECTION 4 0.0002
479 PRODUCT PREPARATION ISSUE 1 0.0002
480 BEDRIDDEN 2 0.0002
481 DISEASE PROGRESSION 18 0.0002
482 IMMUNE SYSTEM DISORDER 2 0.0002
483 PRODUCT FORMULATION ISSUE 1 0.0002
484 ABNORMAL BEHAVIOUR 6 0.0002
485 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
486 APPETITE DISORDER 1 0.0002
487 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
488 JOINT RANGE OF MOTION DECREASED 2 0.0001
489 BREAST MASS 1 0.0001
490 BRONCHIECTASIS 1 0.0001
491 FREQUENT BOWEL MOVEMENTS 4 0.0001
492 OEDEMA PERIPHERAL 18 0.0001
493 TACHYPNOEA 2 0.0001
494 IMPAIRED GASTRIC EMPTYING 2 0.0001
495 EYE MOVEMENT DISORDER 1 0.0001
496 APPLICATION SITE RASH 2 0.0001
497 CARDIAC ARREST 12 0.0001
498 LYMPHOEDEMA 1 0.0001
499 LARGE INTESTINE PERFORATION 1 0.0001
500 COORDINATION ABNORMAL 2 0.0001
501 EXTRASYSTOLES 1 0.0001
502 MASS 2 0.0001
503 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
504 OSTEOARTHRITIS 6 0.0001
505 SEASONAL ALLERGY 2 0.0001
506 SINUS TACHYCARDIA 2 0.0001
507 LIVER FUNCTION TEST INCREASED 3 0.0001
508 SKIN CANCER 3 0.0001
509 IMPAIRED QUALITY OF LIFE 2 0.0001
510 EYE IRRITATION 8 0.0001
511 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
512 PRODUCT PRESCRIBING ISSUE 3 0.0001
513 FAECES SOFT 1 0.0001
514 RASH PUSTULAR 1 0.0001
515 RESPIRATORY FAILURE 10 0.0001
516 DYSPHONIA 8 0.0001
517 DYSURIA 5 0.0001
518 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
519 FEELING DRUNK 1 0.0001
520 PULMONARY MASS 2 0.0001
521 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
522 KETOACIDOSIS 1 0.0001
523 CHROMATURIA 3 0.0001
524 ECONOMIC PROBLEM 2 0.0001
525 AORTIC ANEURYSM 1 0.0001
526 DIABETES MELLITUS 10 0.0001
527 BOWEL MOVEMENT IRREGULARITY 1 0.0001
528 DEVICE RELATED INFECTION 2 0.0001
529 HAEMOLYSIS 1 0.0001
530 MUSCULOSKELETAL CHEST PAIN 2 0.0001
531 CONCUSSION 1 0.0001
532 HYPOALBUMINAEMIA 1 0.0001
533 BASAL CELL CARCINOMA 2 0.0001
534 TREATMENT NONCOMPLIANCE 7 0.0001
535 MULTIPLE ALLERGIES 1 0.0001
536 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
537 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
538 AFFECTIVE DISORDER 1 0.0001
539 PRODUCT USE COMPLAINT 2 0.0001
540 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
541 HEAD INJURY 4 0.0001
542 PNEUMOTHORAX 2 0.0001
543 CYSTITIS 4 0.0001
544 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
545 SENSORY DISTURBANCE 2 0.0001
546 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
547 EYE PAIN 7 0.0001
548 HYPERSENSITIVITY 23 0.0001
549 MYASTHENIA GRAVIS 1 0.0001
550 MUSCLE DISORDER 1 0.0001
551 FLATULENCE 7 0.0001
552 NEURALGIA 3 0.0001
553 PRODUCT DOSE OMISSION 8 0.0001
554 PAIN IN EXTREMITY 36 0.0001
555 ABNORMAL FAECES 1 0.0001
556 METASTASES TO BONE 2 0.0001
557 HERPES ZOSTER 7 0.0001
558 HYPERAESTHESIA 1 0.0001
559 MUSCLE INJURY 1 0.0001
560 BREAST CANCER STAGE II 1 0.0001
561 FUNGAL INFECTION 4 0.0001
562 URINARY RETENTION 4 0.0001
563 PRODUCT DOSE OMISSION ISSUE 35 0.0001
564 UNEVALUABLE EVENT 9 0.0001
565 CANDIDA INFECTION 2 0.0001
566 DRUG RESISTANCE 3 0.0001
567 PRODUCT CONTAINER ISSUE 1 0.0001
568 RECTAL HAEMORRHAGE 5 0.0001
569 RASH GENERALISED 3 0.0001
570 HYSTERECTOMY 1 0.0001
571 HYPERKALAEMIA 4 0.0001
572 GRIP STRENGTH DECREASED 1 0.0001
573 LUNG INFILTRATION 1 0.0001
574 PURPURA 1 0.0001
575 THROMBOSIS 9 0.0001
576 PULMONARY OEDEMA 5 0.0001
577 GASTROINTESTINAL INFECTION 1 0.0001
578 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
579 PAIN OF SKIN 3 0.0001
580 ANAL INCONTINENCE 1 0.0001
581 HEAVY MENSTRUAL BLEEDING 1 0.0001
582 OEDEMA 6 0.0001
583 LEUKOCYTOSIS 2 0.0001
584 PELVIC PAIN 2 0.0001
585 PATHOGEN RESISTANCE 1 0.0001
586 EXOSTOSIS 1 0.0001
587 SKIN LESION 3 0.0001
588 PROCEDURAL PAIN 3 0.0001
589 PNEUMONIA 35 0.0001
590 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
591 PRODUCT DISTRIBUTION ISSUE 1 0.0001
592 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
593 ERYTHEMA MULTIFORME 1 0.0001
594 SWELLING 10 0.0001
595 ILLNESS 11 0.0001
596 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
597 HYPOCALCAEMIA 2 0.0001
598 FEBRILE NEUTROPENIA 7 0.0001
599 FOOT FRACTURE 2 0.0001
600 OCULAR HYPERAEMIA 5 0.0001
601 PRODUCT PACKAGING ISSUE 1 0.0001
602 GASTRIC ULCER 2 0.0001
603 NEOPLASM MALIGNANT 7 0.0001
604 RASH ERYTHEMATOUS 5 0.0001
605 LETHARGY 6 0.0001
606 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
607 PAIN 64 0.0001
608 ATELECTASIS 1 0.0001
609 AUTOIMMUNE DISORDER 1 0.0001
610 PARKINSONISM 1 0.0001
611 HAEMORRHOIDS 2 0.0001
612 SKIN FISSURES 2 0.0001
613 ASCITES 3 0.0001
614 HEPATOMEGALY 1 0.0001
615 ACUTE MYOCARDIAL INFARCTION 3 0.0001
616 KNEE OPERATION 1 0.0001
617 LIGAMENT SPRAIN 1 0.0001
618 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
619 UPPER LIMB FRACTURE 2 0.0001
620 SPINAL FRACTURE 2 0.0001
621 CARDIAC FAILURE 8 0.0001
622 FULL BLOOD COUNT DECREASED 2 0.0001
623 STOMATITIS 6 0.0001
624 HYPOTHERMIA 1 0.0001
625 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
626 MOTOR DYSFUNCTION 1 0.0001
627 FEELING HOT 6 0.0001
628 SKIN BURNING SENSATION 7 0.0001
629 INSOMNIA 26 0.0001
630 EYE DISCHARGE 1 0.0001
631 SWOLLEN TONGUE 3 0.0001
632 CARDIO-RESPIRATORY ARREST 4 0.0001
633 URTICARIA 16 0.0001
634 SPEECH DISORDER 5 0.0001
635 FOLLICULITIS 1 0.0001
636 MOUTH ULCERATION 2 0.0001
637 INCONTINENCE 1 0.0001
638 FULL BLOOD COUNT ABNORMAL 1 0.0001
639 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
640 METABOLIC ACIDOSIS 3 0.0001
641 MOVEMENT DISORDER 3 0.0001
642 BREAST CANCER METASTATIC 1 0.0001
643 NIGHT SWEATS 3 0.0001
644 PHARYNGITIS STREPTOCOCCAL 1 0.0001
645 DEEP VEIN THROMBOSIS 6 0.0001
646 SWELLING FACE 6 0.0001
647 BACK INJURY 1 0.0001
648 DRUG INEFFECTIVE 120 0.0001
649 DENTAL CARIES 1 0.0001
650 VIRAL INFECTION 3 0.0001
651 DEHYDRATION 12 0.0001
652 GAIT INABILITY 3 0.0001
653 RASH 39 0.0001
654 ORAL PAIN 2 0.0001
655 RASH PAPULAR 2 0.0001
656 OCULAR DISCOMFORT 1 0.0001
657 MITRAL VALVE INCOMPETENCE 1 0.0001
658 MYOCARDIAL ISCHAEMIA 1 0.0001
659 INTERNAL HAEMORRHAGE 1 0.0001
660 SKIN IRRITATION 4 0.0001
661 GASTRIC HAEMORRHAGE 1 0.0001
662 MUSCLE TWITCHING 2 0.0001
663 PERICARDIAL EFFUSION 2 0.0001
664 RASH MACULAR 3 0.0001
665 PLATELET COUNT DECREASED 9 0.0001
666 DYSPHAGIA 8 0.0001
667 BLOOD IRON DECREASED 1 0.0001
668 FALL 28 0.0001
669 THERAPY INTERRUPTED 6 0.0001
670 CHOLECYSTITIS 1 0.0001
671 ANAEMIA 16 0.0001
672 MYOCLONUS 1 0.0001
673 ACCIDENT 1 0.0001
674 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
675 CONTUSION 8 0.0001
676 CRYING 3 0.0001
677 ADRENAL INSUFFICIENCY 1 0.0001
678 HYPERGLYCAEMIA 3 0.0001
679 ATRIAL FIBRILLATION 8 0.0001
680 DRUG INTERACTION 13 0.0001
681 BALANCE DISORDER 7 0.0001
682 EYE SWELLING 3 0.0001
683 INJECTION SITE DISCOLOURATION 1 0.0001
684 INTENTIONAL PRODUCT MISUSE 7 0.0001
685 DYSPNOEA EXERTIONAL 3 0.0001
686 DERMATITIS ALLERGIC 1 0.0001
687 MUSCLE ATROPHY 1 0.0001
688 PRURITUS 30 0.0001
689 CONSTIPATION 17 0.0001
690 HAEMOGLOBIN DECREASED 8 0.0001
691 ERYTHEMA 16 0.0001
692 OFF LABEL USE 68 0.0001
693 INFUSION SITE PAIN 1 0.0001
694 INFLAMMATION 4 0.0001
695 ABDOMINAL DISTENSION 8 0.0001
696 NODULE 1 0.0001
697 ECZEMA 4 0.0001
698 ANHEDONIA 2 0.0001
699 DYSMENORRHOEA 1 0.0001
700 EAR INFECTION 2 0.0001
701 DRY SKIN 10 0.0001
702 ASTHENIA 28 0.0001
703 DISTURBANCE IN ATTENTION 4 0.0001
704 RASH PRURITIC 4 0.0001
705 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
706 NEUROPATHY PERIPHERAL 7 0.0001
707 PALLOR 2 0.0001
708 AKATHISIA 1 0.0001
709 OSTEOPOROSIS 3 0.0001
710 DRUG DOSE OMISSION 12 0.0001
711 DIVERTICULITIS 2 0.0001
712 RENAL IMPAIRMENT 6 0.0001
713 CARPAL TUNNEL SYNDROME 1 0.0001
714 DIARRHOEA 46 0.0001
715 DEVICE OCCLUSION 1 0.0001
716 SLEEP DISORDER 5 0.0001
717 LYMPHOPENIA 1 0.0001
718 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
719 PARALYSIS 1 0.0001
720 HYPERSOMNIA 2 0.0001
721 CARDIOGENIC SHOCK 1 0.0001
722 MOBILITY DECREASED 5 0.0001
723 PARAESTHESIA ORAL 1 0.0001
724 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
725 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
726 INJECTION SITE HAEMATOMA 1 0.0001
727 HYPOKINESIA 1 0.0001
728 DYSSTASIA 2 0.0001
729 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
730 WEIGHT DECREASED 19 0.0001
731 VOMITING 32 0.0001
732 LABORATORY TEST ABNORMAL 2 0.0001
733 LIVER DISORDER 3 0.0001
734 BRONCHITIS 5 0.0001
735 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
736 COLON CANCER 1 0.0001
737 IMMUNODEFICIENCY 1 0.0001
738 EPISTAXIS 5 0.0001
739 BONE LOSS 1 0.0001
740 HEPATIC FAILURE 2 0.0001
741 NO ADVERSE EVENT 12 0.0001
742 LACRIMATION INCREASED 2 0.0001
743 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
744 CORONARY ARTERY DISEASE 2 0.0001
745 THERAPEUTIC RESPONSE DECREASED 4 0.0001
746 OSTEOPENIA 1 0.0001
747 LYMPHOMA 1 0.0001
748 DELUSION 1 0.0001
749 DRUG-INDUCED LIVER INJURY 2 0.0001
750 PULMONARY EMBOLISM 6 0.0001
751 PRODUCTIVE COUGH 3 0.0001
752 INFLUENZA 7 0.0001
753 GAIT DISTURBANCE 12 0.0001
754 COVID-19 11 0.0001
755 MUSCLE TIGHTNESS 1 0.0001
756 EYE DISORDER 2 0.0001
757 NAUSEA 48 0.0001
758 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
759 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
760 BLOOD PRESSURE DECREASED 4 0.0001
761 LIP SWELLING 2 0.0001
762 BLOOD UREA INCREASED 1 0.0001
763 SOMNOLENCE 12 0.0001
764 EYE PRURITUS 2 0.0001
765 CONDITION AGGRAVATED 18 0.0001
766 FLUID RETENTION 3 0.0001
767 CIRCULATORY COLLAPSE 1 0.0001
768 PRODUCT USE ISSUE 11 0.0001
769 BLOOD GLUCOSE INCREASED 11 0.0001
770 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
771 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
772 PYREXIA 20 0.0001
773 ORTHOSTATIC HYPOTENSION 1 0.0001
774 DEVICE USE ISSUE 1 0.0001
775 DEPRESSION 13 0.0001
776 HEART RATE DECREASED 2 0.0001
777 METASTASES TO LIVER 1 0.0001
778 DERMATITIS ATOPIC 3 0.0001
779 LYMPHOCYTE COUNT DECREASED 1 0.0001
780 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
781 DYSPNOEA 32 0.0001
782 HEAD DISCOMFORT 1 0.0001
783 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
784 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
785 GALLBLADDER DISORDER 1 0.0001
786 GOUT 1 0.0001
787 GASTROENTERITIS VIRAL 1 0.0001
788 FATIGUE 43 0.0001
789 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
790 UNDERDOSE 4 0.0001
791 RESTLESSNESS 2 0.0001
792 BLOOD GLUCOSE ABNORMAL 1 0.0001
793 HEPATIC STEATOSIS 1 0.0001
794 ABDOMINAL DISCOMFORT 9 0.0001
795 CARDIAC DISORDER 5 0.0001
796 HALLUCINATION 4 0.0001
797 INTESTINAL OBSTRUCTION 2 0.0001
798 FRACTURE 1 0.0001
799 MUSCULAR WEAKNESS 6 0.0001
800 COLITIS 2 0.0001
801 PROTEINURIA 1 0.0001
802 POST PROCEDURAL COMPLICATION 1 0.0001
803 LOWER LIMB FRACTURE 1 0.0001
804 ERUCTATION 1 0.0001
805 PRESCRIBED OVERDOSE 1 0.0001
806 DECREASED APPETITE 12 0.0001
807 BACK PAIN 12 0.0001
808 CHOKING 1 0.0001
809 ORAL HERPES 1 0.0001
810 NASAL CONGESTION 3 0.0001
811 KIDNEY INFECTION 1 0.0001
812 MEMORY IMPAIRMENT 7 0.0001
813 HAEMATOCRIT DECREASED 1 0.0001
814 PRESCRIBED UNDERDOSE 1 0.0001
815 HYPOTENSION 10 0.0000
816 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
817 PRODUCT PHYSICAL ISSUE 1 0.0000
818 CONFUSIONAL STATE 8 0.0000
819 ILL-DEFINED DISORDER 3 0.0000
820 FEEDING DISORDER 1 0.0000
821 PSORIATIC ARTHROPATHY 2 0.0000
822 DYSKINESIA 2 0.0000
823 BONE MARROW FAILURE 1 0.0000
824 DISCOMFORT 3 0.0000
825 NEUTROPHIL COUNT DECREASED 2 0.0000
826 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
827 PERITONITIS 1 0.0000
828 PULMONARY HYPERTENSION 1 0.0000
829 DERMATITIS 1 0.0000
830 HALLUCINATION, VISUAL 1 0.0000
831 HYPERTENSION 10 0.0000
832 JOINT INJURY 1 0.0000
833 PRURITUS GENERALISED 1 0.0000
834 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
835 VAGINAL HAEMORRHAGE 2 0.0000
836 DEVICE DISLOCATION 2 0.0000
837 BLOOD PRESSURE INCREASED 7 0.0000
838 ARTHRALGIA 19 0.0000
839 PRODUCT STORAGE ERROR 4 0.0000
840 ANXIETY 13 0.0000
841 MUSCULOSKELETAL STIFFNESS 4 0.0000
842 MELAENA 1 0.0000
843 TACHYCARDIA 4 0.0000
844 HEART RATE IRREGULAR 1 0.0000
845 SEIZURE 5 0.0000
846 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
847 OROPHARYNGEAL PAIN 4 0.0000
848 CHEST PAIN 8 0.0000
849 BREAST CANCER 4 0.0000
850 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
851 COUGH 12 0.0000
852 INJURY 3 0.0000
853 PRODUCT PRESCRIBING ERROR 1 0.0000
854 BLOOD PRESSURE FLUCTUATION 1 0.0000
855 BLOOD GLUCOSE DECREASED 2 0.0000
856 DIABETIC KETOACIDOSIS 1 0.0000
857 CEREBROVASCULAR ACCIDENT 7 0.0000
858 MENTAL IMPAIRMENT 1 0.0000
859 HYPOGLYCAEMIA 2 0.0000
860 FIBROMYALGIA 1 0.0000
861 PRESYNCOPE 1 0.0000
862 MALAISE 18 0.0000
863 INJECTION SITE URTICARIA 1 0.0000
864 ALOPECIA 8 0.0000
865 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
866 EXTRAPYRAMIDAL DISORDER 1 0.0000
867 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
868 AGEUSIA 1 0.0000
869 LEUKOPENIA 2 0.0000
870 SYNCOPE 4 0.0000
871 HOT FLUSH 3 0.0000
872 HAEMATEMESIS 1 0.0000
873 CARDIOVASCULAR DISORDER 1 0.0000
874 CHEST DISCOMFORT 4 0.0000
875 LOSS OF CONSCIOUSNESS 5 0.0000
876 HAEMATOMA 1 0.0000
877 NERVOUSNESS 2 0.0000
878 HAEMORRHAGE 4 0.0000
879 MUCOSAL INFLAMMATION 1 0.0000
880 GASTRITIS 1 0.0000
881 DEPRESSED MOOD 2 0.0000
882 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
883 FEAR 1 0.0000
884 DRUG EFFECT DECREASED 2 0.0000
885 BLOOD BILIRUBIN INCREASED 1 0.0000
886 MOOD ALTERED 1 0.0000
887 HAEMATOCHEZIA 2 0.0000
888 ANAPHYLACTIC REACTION 2 0.0000
889 TREMOR 6 0.0000
890 DIZZINESS 18 0.0000
891 ARTHROPATHY 2 0.0000
892 FEELING COLD 1 0.0000
893 HAEMOPTYSIS 1 0.0000
894 DEMENTIA 1 0.0000
895 THROMBOCYTOPENIA 4 0.0000
896 HYPONATRAEMIA 2 0.0000
897 ANGINA PECTORIS 1 0.0000
898 MYOCARDIAL INFARCTION 6 0.0000
899 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
900 DRUG WITHDRAWAL SYNDROME 3 0.0000
901 BONE PAIN 2 0.0000
902 CHILLS 4 0.0000
903 CATARACT 2 0.0000
904 ADVERSE DRUG REACTION 3 0.0000
905 FEELING ABNORMAL 8 0.0000
906 PLEURAL EFFUSION 2 0.0000
907 MUSCLE SPASMS 6 0.0000
908 INJECTION SITE RASH 1 0.0000
909 ADVERSE EVENT 3 0.0000
910 EMOTIONAL DISORDER 1 0.0000
911 LIMB DISCOMFORT 1 0.0000
912 NERVOUS SYSTEM DISORDER 1 0.0000
913 BONE DENSITY DECREASED 1 0.0000
914 MIGRAINE 3 0.0000
915 HYPOTHYROIDISM 1 0.0000
916 WEIGHT INCREASED 7 0.0000
917 RHINORRHOEA 2 0.0000
918 LACTIC ACIDOSIS 1 0.0000
919 PSORIASIS 4 0.0000
920 CHOLELITHIASIS 1 0.0000
921 OSTEONECROSIS 1 0.0000
922 ABDOMINAL PAIN 7 0.0000
923 HAEMATURIA 1 0.0000
924 ABDOMINAL PAIN UPPER 6 0.0000
925 INJECTION SITE REACTION 2 0.0000
926 NIGHTMARE 1 0.0000
927 DELIRIUM 1 0.0000
928 HEADACHE 18 0.0000
929 HYPOXIA 1 0.0000
930 LYMPHADENOPATHY 1 0.0000
931 CEREBRAL HAEMORRHAGE 1 0.0000
932 OVERDOSE 6 0.0000
933 ACCIDENTAL OVERDOSE 1 0.0000
934 DYSGEUSIA 2 0.0000
935 HYPOAESTHESIA 4 0.0000
936 DYSARTHRIA 1 0.0000
937 ASTHMA 3 0.0000
938 PLASMA CELL MYELOMA 1 0.0000
939 PALPITATIONS 3 0.0000
940 ARTHRITIS 2 0.0000
941 PARAESTHESIA 4 0.0000
942 DISORIENTATION 1 0.0000
943 JOINT SWELLING 3 0.0000
944 EXTRA DOSE ADMINISTERED 1 0.0000
945 BLINDNESS 1 0.0000
946 LUNG NEOPLASM MALIGNANT 1 0.0000
947 TREATMENT FAILURE 2 0.0000
948 POLLAKIURIA 1 0.0000
949 MENTAL DISORDER 1 0.0000
950 PRODUCT QUALITY ISSUE 3 0.0000
951 INCORRECT DOSE ADMINISTERED 5 0.0000
952 HYPOKALAEMIA 1 0.0000
953 COGNITIVE DISORDER 1 0.0000
954 ARRHYTHMIA 1 0.0000
955 MULTIPLE SCLEROSIS 1 0.0000
956 DRUG INTOLERANCE 2 0.0000
957 INTERSTITIAL LUNG DISEASE 1 0.0000
958 HEART RATE INCREASED 2 0.0000
959 FLUSHING 2 0.0000
960 SINUSITIS 2 0.0000
961 MUSCULOSKELETAL PAIN 1 0.0000
962 BRADYCARDIA 1 0.0000
963 PANCYTOPENIA 1 0.0000
964 NECK PAIN 1 0.0000
965 OXYGEN SATURATION DECREASED 1 0.0000
966 TOXICITY TO VARIOUS AGENTS 3 0.0000
967 RHEUMATOID ARTHRITIS 2 0.0000
968 PRODUCT SUBSTITUTION ISSUE 1 0.0000
969 IRRITABILITY 1 0.0000
970 EMOTIONAL DISTRESS 2 0.0000
971 NASOPHARYNGITIS 3 0.0000
972 AMNESIA 1 0.0000
973 BLOOD CREATININE INCREASED 1 0.0000
974 DEVICE DIFFICULT TO USE 1 0.0000
975 INFUSION RELATED REACTION 1 0.0000
976 HEPATIC ENZYME INCREASED 1 0.0000
977 VISION BLURRED 2 0.0000
978 AGITATION 1 0.0000
979 ACNE 1 0.0000
980 INJECTION SITE HAEMORRHAGE 1 0.0000
981 DRUG DEPENDENCE 2 0.0000
982 DRY MOUTH 1 0.0000
983 INFLUENZA LIKE ILLNESS 1 0.0000
984 MYALGIA 2 0.0000
985 GASTROINTESTINAL DISORDER 1 0.0000
986 DYSPEPSIA 1 0.0000
987 INJECTION SITE ERYTHEMA 1 0.0000
988 HYPERHIDROSIS 1 0.0000
989 NEUTROPENIA 1 0.0000
990 INJECTION SITE PAIN 2 0.0000